These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 34228533

  • 1. Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT).
    Claeys KC, Hopkins TL, Schlaffer K, Hitchcock S, Jiang Y, Evans S, Johnson JK, Leekha S.
    Antimicrob Agents Chemother; 2021 Aug 17; 65(9):e0044121. PubMed ID: 34228533
    [Abstract] [Full Text] [Related]

  • 2. Day at the Races: Comparing BioFire FilmArray Blood Culture ID Panels With Verigene Blood Culture Panel in Gram-Negative Bloodstream Infections Using DOOR-MAT Analysis.
    Claeys KC, Schlaffer K, Smith R, Hitchcock S, Jiang Y, Evans S, Johnson JK, Leekha S.
    Clin Infect Dis; 2021 Sep 15; 73(6):1103-1106. PubMed ID: 33772269
    [Abstract] [Full Text] [Related]

  • 3. A Closer Look at the Laboratory Impact of Utilizing ePlex Blood Culture Identification Panels: a Workflow Analysis Using Rapid Molecular Detection for Positive Blood Cultures.
    Tansarli GS, Chapin KC.
    Microbiol Spectr; 2022 Oct 26; 10(5):e0179622. PubMed ID: 36069598
    [Abstract] [Full Text] [Related]

  • 4. Accuracy of Broad-Panel PCR-Based Bacterial Identification for Blood Cultures in a Pediatric Oncology Population.
    Garner CD, Brazelton de Cardenas J, Suganda S, Hayden RT.
    Microbiol Spectr; 2021 Sep 03; 9(1):e0022121. PubMed ID: 34232100
    [Abstract] [Full Text] [Related]

  • 5. Clinical Performance of the Novel GenMark Dx ePlex Blood Culture ID Gram-Positive Panel.
    Carroll KC, Reid JL, Thornberg A, Whitfield NN, Trainor D, Lewis S, Wakefield T, Davis TE, Church KG, Samuel L, Mills R, Jim P, Young S, Nolte FS.
    J Clin Microbiol; 2020 Mar 25; 58(4):. PubMed ID: 31996444
    [Abstract] [Full Text] [Related]

  • 6. Examining the clinical impact of rapid multiplex polymerase chain reaction-based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration.
    Britt NS, Khader K, He T, Willson TM, Effiong A, Timbrook TT, Potter EM, Lodise TP.
    Pharmacotherapy; 2023 Jan 25; 43(1):24-34. PubMed ID: 36484553
    [Abstract] [Full Text] [Related]

  • 7. The clinical impact of early detection of ESBL-producing Enterobacterales with PCR-based blood culture assays.
    Chang KM, Haghamad A, Saunders-Hao P, Shaffer A, Mirsaidi N, Zimilover A, Epstein M, Jain S, Streva V, Juretschko S, Demissie S, Gautam-Goyal P.
    Am J Infect Control; 2024 Jan 25; 52(1):73-80. PubMed ID: 37544512
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the ePlex Blood Culture Identification Panels for Detection of Pathogens in Bloodstream Infections.
    Huang TD, Melnik E, Bogaerts P, Evrard S, Glupczynski Y.
    J Clin Microbiol; 2019 Feb 25; 57(2):. PubMed ID: 30487304
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Microbiological Performance and the Potential Clinical Impact of the ePlex® Blood Culture Identification Panels for the Rapid Diagnosis of Bacteremia and Fungemia.
    Bryant S, Almahmoud I, Pierre I, Bardet J, Touati S, Maubon D, Cornet M, Richarme C, Maurin M, Pavese P, Caspar Y.
    Front Cell Infect Microbiol; 2020 Feb 25; 10():594951. PubMed ID: 33324578
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The clinical impact of implementing GenMark ePlex blood culture panels for around-the-clock blood culture identification; a prospective observational study.
    Krifors A, Rådberg G, Golbob S, Omar Z, Svensson C, Heimer D, Carlander C.
    Infect Dis (Lond); 2020 Oct 25; 52(10):705-712. PubMed ID: 32522111
    [Abstract] [Full Text] [Related]

  • 15. Implementation and performance of the BioFire FilmArray® Blood Culture Identification panel with antimicrobial treatment recommendations for bloodstream infections at a midwestern academic tertiary hospital.
    Southern TR, VanSchooneveld TC, Bannister DL, Brown TL, Crismon AS, Buss SN, Iwen PC, Fey PD.
    Diagn Microbiol Infect Dis; 2015 Feb 25; 81(2):96-101. PubMed ID: 25488272
    [Abstract] [Full Text] [Related]

  • 16. Rapid testing using the Verigene Gram-negative blood culture nucleic acid test in combination with antimicrobial stewardship intervention against Gram-negative bacteremia.
    Bork JT, Leekha S, Heil EL, Zhao L, Badamas R, Johnson JK.
    Antimicrob Agents Chemother; 2015 Mar 25; 59(3):1588-95. PubMed ID: 25547353
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study.
    Verroken A, Despas N, Rodriguez-Villalobos H, Laterre PF.
    PLoS One; 2019 Mar 25; 14(9):e0223122. PubMed ID: 31557233
    [Abstract] [Full Text] [Related]

  • 19. Impact of a Rapid Blood Culture Diagnostic Panel on Time to Optimal Antimicrobial Therapy at a Veterans Affairs Medical Center.
    Chiasson JM, Smith WJ, Jodlowski TZ, Kouma MA, Cutrell JB.
    J Pharm Pract; 2022 Oct 25; 35(5):722-729. PubMed ID: 33813935
    [Abstract] [Full Text] [Related]

  • 20. Clinical Impact of the Expanded BioFire Blood Culture Identification 2 Panel in a U.S. Children's Hospital.
    Graff KE, Palmer C, Anarestani T, Velasquez D, Hamilton S, Pretty K, Parker S, Dominguez SR.
    Microbiol Spectr; 2021 Sep 03; 9(1):e0042921. PubMed ID: 34431685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.